Format

Send to

Choose Destination
JAMA Oncol. 2018 Jun 1;4(6):874-876. doi: 10.1001/jamaoncol.2018.0275.

Evaluating Treatment Effect Based on Duration of Response for a Comparative Oncology Study.

Author information

1
Pfizer Inc, Groton, Connecticut.
2
Stanford Medical School, Stanford University, Stanford, California.
3
Pfizer Inc, New York, New York.
4
Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
5
Department of Biostatistics, Harvard University, Boston, Massachusetts.
PMID:
29710201
PMCID:
PMC6584319
DOI:
10.1001/jamaoncol.2018.0275
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Silverchair Information Systems Icon for PubMed Central
Loading ...
Support Center